Genetic inactivation of TRAF3 in canine and human B-cell lymphoma-Reference-Cited by-同舟云学术

Genetic inactivation of TRAF3 in canine and human B-cell lymphoma

Published:2015-02-05 Issue:6 Volume:125 Page:999-1005
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Bushell Kevin R.¹,Kim Yukyoung¹,Chan Fong Chun²³,Ben-Neriah Susana²,Jenks Andrew¹,Alcaide Miguel¹,Fornika Daniel¹^ORCID,Grande Bruno M.¹^ORCID,Arthur Sarah¹,Gascoyne Randy D.²,Steidl Christian²,Morin Ryan D.¹⁴^ORCID

Affiliation:

1. Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada;

2. Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;

3. Bioinformatics Graduate Program, University of British Columbia, Vancouver, BC, Canada; and

4. Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada

Abstract

Key Points TRAF3 is genetically inactivated in a substantial fraction of cBCLs. Focal genetic loss of TRAF3 is recurrent in human DLBCLs.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/125/6/999/1387737/999.pdf

Reference58 articles.

1. Spontaneously occurring tumors of companion animals as models for human cancer.;Vail;Cancer Invest,2000

2. Translation of new cancer treatments from pet dogs to humans.;Paoloni;Nat Rev Cancer,2008

3. Dog models of naturally occurring cancer.;Rowell;Trends Mol Med,2011

4. Cancer statistics, 2013.;Siegel;CA Cancer J Clin,2013

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Analysis of Microsatellite Instability in Canine Cancers: Implications for Comparative Oncology and Personalized Veterinary Medicine;Animals;2024-08-27

2. The K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classification;Scientific Reports;2024-08-12

3. TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma;Proceedings of the National Academy of Sciences;2024-04-25

4. Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential;Veterinary and Comparative Oncology;2023-12-05

5. Shared hotspot mutations in oncogenes position dogs as an unparalleled comparative model for precision therapeutics;Scientific Reports;2023-07-06